Atlas Trials

Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer

Clinical trial NCT06826079 · RECRUITING

Trial details

NCT number
NCT06826079
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Junction AdenocarcinomaGastric CancerImmunotherapyNeoadjuvant Therapies
Start date
2024-11-01
Primary completion
2028-08-01
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.